Evaluation of the potential of ultrasound-mediated drug delivery for the treatment of ovarian cancer through preclinical studies

Ovarian cancer (OC) has the greatest mortality rate among gynecological cancers, with a five-year survival rate of <50%. Contemporary adjuvant chemotherapy mostly fails in the case of OCs that are refractory, metastatic, recurrent, and drug-resistant. Emerging ultrasound (US)-mediated technologie...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yi-Chao, Tian, Jing-Yan, Han, Ying-Ying, Liu, Yun-Fei, Chen, Si-Yao, Guo, Feng-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483181/
https://www.ncbi.nlm.nih.gov/pubmed/36132133
http://dx.doi.org/10.3389/fonc.2022.978603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483181/
https://www.ncbi.nlm.nih.gov/pubmed/36132133
http://dx.doi.org/10.3389/fonc.2022.978603

Ejemplares similares